Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/1078
| Predicate | Object |
|---|---|
| rdf:type | |
| rdfs:label |
SEROQUEL XR (Tablet, Extended Release)
|
| dailymed-instance:activeIng... | |
| dailymed-instance:boxedWarn... |
WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS: Elderly patients with dementia-related psychosis treated with atypical antipsychotic drugs are at an increased risk of death compared to placebo. Analyses of seventeen placebo-controlled trials (modal duration of 10 weeks) in these patients revealed a risk of death in the drug-treated patients of between 1.6 to 1.7 times that seen in placebo-treated patients. Overthe course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (eg, heart failure, sudden death) or infectious (eg, pneumonia) in nature. SEROQUEL XR is not approved for the treatment of patients with Dementia-Related Psychosis.
|
| dailymed-instance:activeMoi... | |
| dailymed-instance:inactiveI... |
dailymed-ingredient:hypromellose,
dailymed-ingredient:lactose_monohydrate,
dailymed-ingredient:magnesium_stearate,
dailymed-ingredient:microcrystalline_cellulose,
dailymed-ingredient:polyethylene_glycol_400,
dailymed-ingredient:sodium_citrate,
dailymed-ingredient:titanium_dioxide,
dailymed-ingredient:yellow_iron_oxide
|
| dailymed-instance:genericMe... |
Quetiapine fumarate
|
| dailymed-instance:fullName |
SEROQUEL XR (Tablet, Extended Release)
|
| dailymed-instance:represent... | |
| dailymed-instance:routeOfAd... | |
| dailymed-instance:name |
SEROQUEL XR
|